| Financial Year |
March 31 2023 |
| Monetary Funds |
186,527,969.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,897,411.73 |
| Accounts Receivable |
679,575,977.42 |
| Advances to Suppliers |
176,850,970.27 |
| Other Receivables |
15,393,312.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,688,721,194.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,014,802.94 |
| Total Current Assets |
2,821,210,040.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
289,628,046.11 |
| Fixed Assetes |
209,407,156.09 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
135,561,912.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
203,046.61 |
| Deferred Income Tax Assets |
15,352,054.51 |
| Other Non-Current Assets |
2,533,894.90 |
| Sub-Total of Non-Current Assets |
660,749,591.56 |
| Total Assets |
3,481,959,631.56 |
| Short-Term Loans |
271,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,480,902.70 |
| Accounts Payable |
687,118,031.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,736,036.62 |
| Taxes Payable |
16,638,803.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,931,683.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,296,394.48 |
| Other Current Liabilities |
26,492,812.40 |
| Sub-Total of Current Liabilities |
1,713,374,825.58 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
82,939.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
50,688,326.27 |
| Total Liabilities |
1,764,063,151.85 |
| Paid-In Capital(Or Share Stock) |
717,767,936.00 |
| Capital Surplus |
456,124,748.49 |
| Surplus Reserve |
62,989,643.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
475,049,970.91 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,717,896,479.71 |
| Owner's Equity（Stockholder's Equity） |
1,717,896,479.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,481,959,631.56 |
